These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 27590365)

  • 1. Uterine sarcoma Part I-Uterine leiomyosarcoma: The Topic Advisory Group systematic review.
    Wen KC; Horng HC; Wang PH; Chen YJ; Yen MS; Ng HT;
    Taiwan J Obstet Gynecol; 2016 Aug; 55(4):463-71. PubMed ID: 27590365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
    Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
    Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of current staging systems and a novel staging system for uterine leiomyosarcoma.
    Giuntoli RL; Lessard-Anderson CR; Gerardi MA; Kushnir CL; Cliby WA; Metzinger DS; Gostout BS
    Int J Gynecol Cancer; 2013 Jun; 23(5):869-76. PubMed ID: 23669444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging of uterine sarcomas.
    Tse KY; Crawford R; Ngan HY
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):733-49. PubMed ID: 21752716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and treatment outcomes in 93 patients with uterine sarcoma from 4 centers in Turkey.
    Durnali A; Tokluoğlu S; Özdemir N; Inanç M; Alkiş N; Zengin N; Sönmez ÖU; Küçüköner M;
    Asian Pac J Cancer Prev; 2012; 13(5):1935-41. PubMed ID: 22901150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine sarcomas: a review.
    D'Angelo E; Prat J
    Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
    D'Angelo E; Spagnoli LG; Prat J
    Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine sarcomas.
    Mbatani N; Olawaiye AB; Prat J
    Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():51-58. PubMed ID: 30306577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myxoid leiomyosarcoma of the uterus: a clinicopathological and immunohistochemical study of 10 cases.
    Lu B; Shi H; Zhang X
    Hum Pathol; 2017 Jan; 59():139-146. PubMed ID: 27717885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine sarcomas: clinical presentation and MRI features.
    Santos P; Cunha TM
    Diagn Interv Radiol; 2015; 21(1):4-9. PubMed ID: 25347940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine sarcoma part III-Targeted therapy: The Taiwan Association of Gynecology (TAG) systematic review.
    Yen MS; Chen JR; Wang PH; Wen KC; Chen YJ; Ng HT;
    Taiwan J Obstet Gynecol; 2016 Oct; 55(5):625-634. PubMed ID: 27751406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the treatment of sarcomas in gynecology.
    Lange SS; Novetsky AP; Powell MA
    Discov Med; 2014 Sep; 18(98):133-40. PubMed ID: 25227754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic treatment in adult uterine sarcomas.
    Desar IME; Ottevanger PB; Benson C; van der Graaf WTA
    Crit Rev Oncol Hematol; 2018 Feb; 122():10-20. PubMed ID: 29458779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine leiomyosarcoma.
    Hannigan EV; Gomez LG
    Am J Obstet Gynecol; 1979 Jul; 134(5):557-64. PubMed ID: 453295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gynecologic Cancer InterGroup (GCIG) consensus review for high-grade undifferentiated sarcomas of the uterus.
    Pautier P; Nam EJ; Provencher DM; Hamilton AL; Mangili G; Siddiqui NA; Westermann AM; Reed NS; Harter P; Ray-Coquard I
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S73-7. PubMed ID: 25341584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathologic characteristics and prognosis factors of uterine sarcomas in central Tunisia].
    Khlifi A; Fathallah K; Zbidi C; Hidar S; Bibi M; Khairi H
    Bull Cancer; 2014; 101(7-8):669-80. PubMed ID: 25091649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.
    Burghaus S; Halmen S; Gass P; Mehlhorn G; Schrauder MG; Lux MP; Renner SP; Beckmann MW; Hein A; Thiel FC
    Arch Gynecol Obstet; 2016 Aug; 294(2):343-51. PubMed ID: 26711836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Uterine sarcoma in Tunisia: retrospective study about 14 cases].
    Bouzid N; Kanoun Belajouza S; Boussen H; Bouaouina N
    Gynecol Obstet Fertil; 2014 Dec; 42(12):838-43. PubMed ID: 25155830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine sarcoma: a clinicopathological study of 93 cases.
    González-Bosquet E; Martínez-Palones JM; González-Bosquet J; García Jiménez A; Xercavins J
    Eur J Gynaecol Oncol; 1997; 18(3):192-5. PubMed ID: 9174834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence.
    Goff BA; Rice LW; Fleischhacker D; Muntz HG; Falkenberry SS; Nikrui N; Fuller AF
    Gynecol Oncol; 1993 Jul; 50(1):105-9. PubMed ID: 8349151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.